+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PET-CT Scanner Device Market Size, Share & Industry Trends Analysis Report By Slice Count, By Isotope/Detector Type, By Service Provider, By Type, By Application, By Regional Outlook and Forecast, 2021-2027

  • PDF Icon

    Report

  • 328 Pages
  • February 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5571157
The Global PET-CT Scanner Device Market size is expected to reach $2.6 billion by 2027, rising at a market growth of 5.5% CAGR during the forecast period.

PET imaging or a PET scan is another name for positron emission tomography, which is a sort of nuclear medicine imaging. It evaluates organ and tissue functions using small amounts of radioactive materials called radiotracers or radiopharmaceuticals, a special camera, and a computer. In addition, by detecting changes at the cellular level, it can detect the early onset of disease before other imaging tests. Moreover, it can detect heart illness, cancer, gastrointestinal, endocrine, and neurological issues, among other conditions. The radiotracers utilized in it tend to accumulate in tumors or inflammatory areas and bind to certain proteins in the body.

PET-CT, which is regarded as a high-end technique, has gained widespread adoption because of its excellent quality, accuracy, precision, and versatility in diagnosis. Additionally, the integration of PET and CT in a single system is seen as an advancement in imaging technology, as the combination of two well-established modalities provides greater benefits than the sum of their parts. Moreover, CT scanners provide high-resolution images of the anatomy.

Also, malignant disorders can only be detected with this technique, starting with observing changes in lymph node size or the existence of aberrant masses. On the other hand, for a lymph node that is normal in size, PET can completely identify a functional anomaly. As a result, combining PET/CT systems allows for a better functional assessment of anatomical scan abnormalities as well as improved spatial localization of functional abnormalities.



COVID-19 Impact Analysis


PET imaging allows researchers to track COVID-19's key pathophysiological changes at the molecular level, providing crucial information for the disease's subsequent diagnosis, evaluation, and treatment. The most widely employed PET imaging agent in COVID-19 patients is F-labeled fluorodeoxyglucose (18F-FDG), a radiolabeled glucose analog, and the integrated PET/CT system can be used to evaluate the functional and structural alterations of COVID-19 at the same time. In addition, the adoption of devices in the diagnosis and evaluation of the COVID-19 fueled the demand for these devices during the pandemic period. Moreover, cancer patients who receive radiation therapy have a higher risk of developing a more serious condition.

Market Growth Factors:


Growing occurrence of chronic diseases and the growing elderly population


In the last couple of years, there has been a rising prevalence of infectious and chronic diseases such as cancer and heart disease around the world, as well as increased demand for better diagnostic technologies. Globally, an estimated 14.1 million new cancer cases were recorded in 2012, according to the International Agency for Research on Cancer (IARC). Among these, Lung cancer (13%) was the most prevalent type, followed by breast cancer (11.9%) and colorectal cancer (11.9%). (9.7 percent). In addition, increased cases of brain diseases including Alzheimer's and traumatic brain injury are fueling market expansion. Moreover, the number of newly diagnosed cancer cases and cancer fatalities across the world is expected to increase significantly. Furthermore, Scanner advancements now allow for better localization of activity to normal vs. aberrant structures, as well as faster scan times than earlier versions.

The rise in deployment of PET/CT systems in clinical applications


PET-only scanners had an equivalent of extremely crude built-in CT scanners that used PET detectors such as crude CT detectors prior to the advent of PET/CT systems. The pictures produced by these CT-equivalent systems were non-diagnostic and highly sluggish. Furthermore, they exposed patients to more radiation. Hence, Correction images exposure was introduced into PET/CT systems. Moreover, PET/CT scanners are also quicker, which helps to eliminate motion artifacts. Because of the unique combination of functional information received with PET and anatomic information gathered with CT, PET/CT systems have seen an increase in usage since their introduction into clinical practice.

Market Restraining Factors


High Installation & Maintenance Costs


One of the biggest challenges faced by the industry players is high maintenance and installation costs of these systems. Due to the considerable capital necessary for the latest technology, and with a huge and controlled refurbished systems business, especially in developing nations has hampered the adoption of new and innovative systems. In addition, major global and domestic players have entered this profitable industry, offering refurbished equipment to healthcare facilities around the world at inexpensive pricing. Moreover, Healthcare institutions prefer low-cost reconditioned equipment over new products. Further, there are unsupportive healthcare reimbursement scenarios in many countries. Globally, decreased payer reimbursement for PET and SPECT procedures has resulted in a drop in outpatient volumes, limiting patient access to high-quality, low-cost imaging and diagnostic services.



Slice Count Outlook


Based on Slice Count, the market is segmented into Medium Slice Cardiology (64 Slices), Low Slice Cardiology (< 64 Slices), and High Slice Cardiology (>64 Slices). The Low Slice Cardiology (< 64 Slices) segment obtained a significant revenue share of the PET-CT Scanner Device Market. This is due to the high occurrence of medical implants, shifting food habits, and acceptance of sedentary lifestyles. Moreover, constant developments in imaging devices with the help of R&D efforts is expected to drive the growth of the segment during the forecasting period.

Isotope/Detector Type Outlook


Based on Isotope/Detector Type, the market is segmented into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. In 2020, the Flurodeoxyglucose (FDG) segment obtained the highest revenue share of the PET-CT Scanner Devices Market. F-18 fluorodeoxyglucose (FDG), for example, is a common radiotracer that is absorbed by cancer cells. This is because of the increasing number of FDG applications, a decrease in the number of FDG adverse effects, and an increase in the incidence of chronic diseases. Moreover, it provides a number of advantages, including the ability to provide more detail with a higher level of accuracy.

Service Provider Outlook


Based on Service Provider, the market is segmented into Hospitals, Diagnostic Centers, and Research Institutes. In 2020, the Hospitals segment collected the maximum revenue share of the PET-CT Scanner Device Market. This is due to an increase in the number of hospitals, a surge in patient awareness toward treatment in hospitals, increased healthcare infrastructure, and increased adoption of PET-CT scanner devices.

Type Outlook


Based on Type, the market is segmented into Stationary Scanners and Portable Scanners/Mobile Scanners. The Portable Scanners/Mobile Scanners segment held a significant revenue share of the PET-CT Scanner Device Market. This is because small and medium-sized healthcare organizations are increasingly turning to mobile devices. Moreover, lower expenses, faster installation time, cheap initial investment, and reduced patient travel are some of the advantages of the mobile device category. Leading manufacturers such as GE, Philips, and Siemens provide a variety of portable PET-CT scanners.

Application Outlook


Based on Application, the market is segmented into Oncology, Cardiology, Neurology, and Others. In 2020, the Cardiology segment obtained a significant revenue share of the PET-CT Scanner Device Market. A cardiac positron emission tomography (PET) scan uses a small quantity of radioactivity to examine the heart muscle. When compared to conventional nuclear stress testing methods, cardiac PET/CT provides higher accuracy, reduced radiation, and increased efficiency in the diagnosis of coronary artery disease (SPECT). Patients with a high body mass index, or BMI, or a considerable amount of breast/chest wall tissue, breast implants, or pleural or pericardial effusions may benefit from cardiac PET/CT.

Regional Outlook


Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2020, the North America emerged as the leading region in the overall PET-CT Scanner Device Market. This is due to an increase in the number of chronic disease patients, an increase in the demand for PET-CT scan devices, the availability of advanced healthcare facilities with trained medical professionals, an increase in the number of R&D activities with a large presence of key players, and an increase in government investment in the healthcare system.

Cardinal Matrix - PET-CT Scanner Device Market Competition Analysis




The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; General Electric (GE) Co. and Hitachi, Ltd. are the forerunners in the PET-CT Scanner Device Market. Companies such as Bruker Corporation, Toshiba Corporation, and Siemens Healthineers AG are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Toshiba Corporation, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Shimadzu Corporation, Positron Corporation, PerkinElmer, Inc., Mediso Ltd., and Hitachi, Ltd. (Hitachi Healthcare).

Recent Strategies Deployed in PET-CT Scanner Device Market


Partnerships, Collaborations and Agreements:

  • Jan-2022: Positron Corporation partnered with Neusoft Medical Systems, a leading global clinical diagnosis, and treatment solution provider, for manufacturing, distribution, and continued R&D advancements of Positron’s new PET/CT nuclear imaging device. Following the partnership, the two companies is expected to together integrate their PET/CT technology and services for nuclear cardiology while expanding the capabilities in the domain of oncology imaging diagnostics and clinical services.
  • Jul-2021: GE Healthcare joined hands with Quibim, a global leader in artificial intelligence (AI) and medical image processing. Under this collaboration, the two companies is expected to together take part in a High Sensitivity Molecular Imaging project IMAS (Imagen Molecular de Alta Sensibilidad) to develop an advanced total-body PET/CT scanner for simultaneous whole-body imaging in a Temporary Business Association (TBA).
  • Jul-2021: GE Healthcare collaborated with SOPHiA GENETICS, an American Swiss biotechnology company. Following the collaboration, the two companies is expected to work on advancing cancer care in order to provide effective targeting and matching treatments to every patient's genomic profile and cancer type, assisting to enable the most efficient and tailored treatment.

Acquisitions and Mergers:

  • Nov-2021: Bruker Corporation today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. The acquisition of MOLECUBES adds scalable benchtop instruments to our portfolio for serving the NMI preclinical research community. The synergies between our and MOLECUBES’ research and development, applications and service teams is expected to benefit our combined NMI customers worldwide.
  • May-2021: GE Healthcare took over Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that assist to allow more personalized healthcare. In addition, the company is expected to develop and commercialize pipeline biomarkers of Zionexa and newly FDA-approved imaging agent, Cerianna (fluoroestradiol F-18), which is utilized as an adjunct to biopsy for detecting oestrogen receptor (ER) positive lesions in patients with recurrent or metastatic breast cancer to help advise treatment choices.

Product Launches and Product Expansions:

  • May-2021: GE Healthcare introduced Xeleris V, a new virtual processing and review solution. Moreover, Xeleris V helps to get rid of the requirement for a standalone nuclear medicine workstation so that clinicians can safely access data from several locations. In addition, Xeleris V and its sophisticated AI capabilities, paired with GE Healthcare's 800 and 600 Series nuclear medicine scanners, give doctors quick and easy access to the information they need to make tailored treatment decisions.
  • Mar-2021: Shimadzu Corporation unveiled a new BresTome TOF-PET functional imaging system dedicated for head and breast within the Japanese domestic market. The new system provides double resolution of common whole-body PET systems. It can be utilized to support the clinical treatment of Alzheimer's disease and other degenerative neurological diseases along with therapeutic applications for brain tumors and epilepsy covered by Japanese public health insurance.
  • Oct-2020: Siemens Healthineers rolled out Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner. The new solution is developed for clinical use as well as translational research or the application of scientific research to develop therapies and procedures that enhance health outcomes.

Approvals and Trials:

  • Mar-2021: Siemens Healthineers received the approval of the Food and Drug Administration (FDA) for Biograph Vision Quadra, a positron emission tomography/computed tomography (PET/CT) scanner developed for clinical usage and translational research or the application of scientific research to develop effective therapies and procedures that can enhance health outcomes. Through this approval, the company aimed to expand its portfolio of precision medicine.
  • Apr-2020: Siemens Healthineers got Food and Drug Administration (FDA) approval for its AIDAN artificial intelligence technologies on the Biograph family of positron emission tomography/computed tomography (PET/CT) systems, which includes the Biograph Horizon, Biograph mCT, and Biograph Vision. These systems provide improved protection against cyber threats through syngo Security, a security package for general regulatory security rules that allows compliance with the Health Insurance and Accountability Act (HIPAA).

Scope of the Study


Market Segments Covered in the Report:


By Slice Count
  • Medium Slice Cardiology (64 Slices)
  • Low Slice Cardiology (< 64 Slices)
  • High Slice Cardiology (>64 Slices)

By Isotope/Detector Type
  • Flurodeoxyglucose (FDG)
  • 62Cu ATSM
  • 18 F Sodium Fluoride
  • FMISO
  • Gallium
  • Thallium
  • Others

By Service Provider
  • Hospitals
  • Diagnostic Centers
  • Research Institutes

By Type
  • Stationary Scanners
  • Portable Scanners/Mobile Scanners

By Application
  • Oncology
  • Cardiology
  • Neurology
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Bruker Corporation
  • Toshiba Corporation
  • Siemens Healthineers AG (Siemens AG)
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • Positron Corporation
  • PerkinElmer, Inc.
  • Mediso Ltd.
  • Hitachi, Ltd. (Hitachi Healthcare)

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global PET-CT Scanner Device Market, by Slice Count
1.4.2 Global PET-CT Scanner Device Market, by Isotope/Detector Type
1.4.3 Global PET-CT Scanner Device Market, by Service Provider
1.4.4 Global PET-CT Scanner Device Market, by Type
1.4.5 Global PET-CT Scanner Device Market, by Application
1.4.6 Global PET-CT Scanner Device Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
Chapter 4. Global PET-CT Scanner Device Market by Slice Count
4.1 Global Medium Slice Cardiology (64 Slices) Market by Region
4.2 Global Low Slice Cardiology (< 64 Slices) Market by Region
4.3 Global High Slice Cardiology (>64 Slices) Market by Region
Chapter 5. Global PET-CT Scanner Device Market by Isotope/Detector Type
5.1 Global Flurodeoxyglucose (FDG) Market by Region
5.2 Global 62Cu ATSM Market by Region
5.3 Global 18 F Sodium Fluoride Market by Region
5.4 Global FMISO Market by Region
5.5 Global Gallium Market by Region
5.6 Global Thallium Market by Region
5.7 Global Others Market by Region
Chapter 6. Global PET-CT Scanner Device Market by Service Provider
6.1 Global Hospitals Market by Region
6.2 Global Diagnostic Centers Market by Region
6.3 Global Research Institutes Market by Region
Chapter 7. Global PET-CT Scanner Device Market by Type
7.1 Global Stationary Scanners Market by Region
7.2 Global Portable Scanners/Mobile Scanners Market by Region
Chapter 8. Global PET-CT Scanner Device Market by Application
8.1 Global Oncology Market by Region
8.2 Global Cardiology Market by Region
8.3 Global Neurology Market by Region
8.4 Global Others Market by Region
Chapter 9. Global PET-CT Scanner Device Market by Region
9.1 North America PET-CT Scanner Device Market
9.1.1 North America PET-CT Scanner Device Market by Slice Count
9.1.1.1 North America Medium Slice Cardiology (64 Slices) Market by Country
9.1.1.2 North America Low Slice Cardiology (< 64 Slices) Market by Country
9.1.1.3 North America High Slice Cardiology (>64 Slices) Market by Country
9.1.2 North America PET-CT Scanner Device Market by Isotope/Detector Type
9.1.2.1 North America Flurodeoxyglucose (FDG) Market by Country
9.1.2.2 North America 62Cu ATSM Market by Country
9.1.2.3 North America 18 F Sodium Fluoride Market by Country
9.1.2.4 North America FMISO Market by Country
9.1.2.5 North America Gallium Market by Country
9.1.2.6 North America Thallium Market by Country
9.1.2.7 North America Others Market by Country
9.1.3 North America PET-CT Scanner Device Market by Service Provider
9.1.3.1 North America Hospitals Market by Country
9.1.3.2 North America Diagnostic Centers Market by Country
9.1.3.3 North America Research Institutes Market by Country
9.1.4 North America PET-CT Scanner Device Market by Type
9.1.4.1 North America Stationary Scanners Market by Country
9.1.4.2 North America Portable Scanners/Mobile Scanners Market by Country
9.1.5 North America PET-CT Scanner Device Market by Application
9.1.5.1 North America Oncology Market by Country
9.1.5.2 North America Cardiology Market by Country
9.1.5.3 North America Neurology Market by Country
9.1.5.4 North America Others Market by Country
9.1.6 North America PET-CT Scanner Device Market by Country
9.1.6.1 US PET-CT Scanner Device Market
9.1.6.1.1 US PET-CT Scanner Device Market by Slice Count
9.1.6.1.2 US PET-CT Scanner Device Market by Isotope/Detector Type
9.1.6.1.3 US PET-CT Scanner Device Market by Service Provider
9.1.6.1.4 US PET-CT Scanner Device Market by Type
9.1.6.1.5 US PET-CT Scanner Device Market by Application
9.1.6.2 Canada PET-CT Scanner Device Market
9.1.6.2.1 Canada PET-CT Scanner Device Market by Slice Count
9.1.6.2.2 Canada PET-CT Scanner Device Market by Isotope/Detector Type
9.1.6.2.3 Canada PET-CT Scanner Device Market by Service Provider
9.1.6.2.4 Canada PET-CT Scanner Device Market by Type
9.1.6.2.5 Canada PET-CT Scanner Device Market by Application
9.1.6.3 Mexico PET-CT Scanner Device Market
9.1.6.3.1 Mexico PET-CT Scanner Device Market by Slice Count
9.1.6.3.2 Mexico PET-CT Scanner Device Market by Isotope/Detector Type
9.1.6.3.3 Mexico PET-CT Scanner Device Market by Service Provider
9.1.6.3.4 Mexico PET-CT Scanner Device Market by Type
9.1.6.3.5 Mexico PET-CT Scanner Device Market by Application
9.1.6.4 Rest of North America PET-CT Scanner Device Market
9.1.6.4.1 Rest of North America PET-CT Scanner Device Market by Slice Count
9.1.6.4.2 Rest of North America PET-CT Scanner Device Market by Isotope/Detector Type
9.1.6.4.3 Rest of North America PET-CT Scanner Device Market by Service Provider
9.1.6.4.4 Rest of North America PET-CT Scanner Device Market by Type
9.1.6.4.5 Rest of North America PET-CT Scanner Device Market by Application
9.2 Europe PET-CT Scanner Device Market
9.2.1 Europe PET-CT Scanner Device Market by Slice Count
9.2.1.1 Europe Medium Slice Cardiology (64 Slices) Market by Country
9.2.1.2 Europe Low Slice Cardiology (< 64 Slices) Market by Country
9.2.1.3 Europe High Slice Cardiology (>64 Slices) Market by Country
9.2.2 Europe PET-CT Scanner Device Market by Isotope/Detector Type
9.2.2.1 Europe Flurodeoxyglucose (FDG) Market by Country
9.2.2.2 Europe 62Cu ATSM Market by Country
9.2.2.3 Europe 18 F Sodium Fluoride Market by Country
9.2.2.4 Europe FMISO Market by Country
9.2.2.5 Europe Gallium Market by Country
9.2.2.6 Europe Thallium Market by Country
9.2.2.7 Europe Others Market by Country
9.2.3 Europe PET-CT Scanner Device Market by Service Provider
9.2.3.1 Europe Hospitals Market by Country
9.2.3.2 Europe Diagnostic Centers Market by Country
9.2.3.3 Europe Research Institutes Market by Country
9.2.4 Europe PET-CT Scanner Device Market by Type
9.2.4.1 Europe Stationary Scanners Market by Country
9.2.4.2 Europe Portable Scanners/Mobile Scanners Market by Country
9.2.5 Europe PET-CT Scanner Device Market by Application
9.2.5.1 Europe Oncology Market by Country
9.2.5.2 Europe Cardiology Market by Country
9.2.5.3 Europe Neurology Market by Country
9.2.5.4 Europe Others Market by Country
9.2.6 Europe PET-CT Scanner Device Market by Country
9.2.6.1 Germany PET-CT Scanner Device Market
9.2.6.1.1 Germany PET-CT Scanner Device Market by Slice Count
9.2.6.1.2 Germany PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.1.3 Germany PET-CT Scanner Device Market by Service Provider
9.2.6.1.4 Germany PET-CT Scanner Device Market by Type
9.2.6.1.5 Germany PET-CT Scanner Device Market by Application
9.2.6.2 UK PET-CT Scanner Device Market
9.2.6.2.1 UK PET-CT Scanner Device Market by Slice Count
9.2.6.2.2 UK PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.2.3 UK PET-CT Scanner Device Market by Service Provider
9.2.6.2.4 UK PET-CT Scanner Device Market by Type
9.2.6.2.5 UK PET-CT Scanner Device Market by Application
9.2.6.3 France PET-CT Scanner Device Market
9.2.6.3.1 France PET-CT Scanner Device Market by Slice Count
9.2.6.3.2 France PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.3.3 France PET-CT Scanner Device Market by Service Provider
9.2.6.3.4 France PET-CT Scanner Device Market by Type
9.2.6.3.5 France PET-CT Scanner Device Market by Application
9.2.6.4 Russia PET-CT Scanner Device Market
9.2.6.4.1 Russia PET-CT Scanner Device Market by Slice Count
9.2.6.4.2 Russia PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.4.3 Russia PET-CT Scanner Device Market by Service Provider
9.2.6.4.4 Russia PET-CT Scanner Device Market by Type
9.2.6.4.5 Russia PET-CT Scanner Device Market by Application
9.2.6.5 Spain PET-CT Scanner Device Market
9.2.6.5.1 Spain PET-CT Scanner Device Market by Slice Count
9.2.6.5.2 Spain PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.5.3 Spain PET-CT Scanner Device Market by Service Provider
9.2.6.5.4 Spain PET-CT Scanner Device Market by Type
9.2.6.5.5 Spain PET-CT Scanner Device Market by Application
9.2.6.6 Italy PET-CT Scanner Device Market
9.2.6.6.1 Italy PET-CT Scanner Device Market by Slice Count
9.2.6.6.2 Italy PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.6.3 Italy PET-CT Scanner Device Market by Service Provider
9.2.6.6.4 Italy PET-CT Scanner Device Market by Type
9.2.6.6.5 Italy PET-CT Scanner Device Market by Application
9.2.6.7 Rest of Europe PET-CT Scanner Device Market
9.2.6.7.1 Rest of Europe PET-CT Scanner Device Market by Slice Count
9.2.6.7.2 Rest of Europe PET-CT Scanner Device Market by Isotope/Detector Type
9.2.6.7.3 Rest of Europe PET-CT Scanner Device Market by Service Provider
9.2.6.7.4 Rest of Europe PET-CT Scanner Device Market by Type
9.2.6.7.5 Rest of Europe PET-CT Scanner Device Market by Application
9.3 Asia Pacific PET-CT Scanner Device Market
9.3.1 Asia Pacific PET-CT Scanner Device Market by Slice Count
9.3.1.1 Asia Pacific Medium Slice Cardiology (64 Slices) Market by Country
9.3.1.2 Asia Pacific Low Slice Cardiology (< 64 Slices) Market by Country
9.3.1.3 Asia Pacific High Slice Cardiology (>64 Slices) Market by Country
9.3.2 Asia Pacific PET-CT Scanner Device Market by Isotope/Detector Type
9.3.2.1 Asia Pacific Flurodeoxyglucose (FDG) Market by Country
9.3.2.2 Asia Pacific 62Cu ATSM Market by Country
9.3.2.3 Asia Pacific 18 F Sodium Fluoride Market by Country
9.3.2.4 Asia Pacific FMISO Market by Country
9.3.2.5 Asia Pacific Gallium Market by Country
9.3.2.6 Asia Pacific Thallium Market by Country
9.3.2.7 Asia Pacific Others Market by Country
9.3.3 Asia Pacific PET-CT Scanner Device Market by Service Provider
9.3.3.1 Asia Pacific Hospitals Market by Country
9.3.3.2 Asia Pacific Diagnostic Centers Market by Country
9.3.3.3 Asia Pacific Research Institutes Market by Country
9.3.4 Asia Pacific PET-CT Scanner Device Market by Type
9.3.4.1 Asia Pacific Stationary Scanners Market by Country
9.3.4.2 Asia Pacific Portable Scanners/Mobile Scanners Market by Country
9.3.5 Asia Pacific PET-CT Scanner Device Market by Application
9.3.5.1 Asia Pacific Oncology Market by Country
9.3.5.2 Asia Pacific Cardiology Market by Country
9.3.5.3 Asia Pacific Neurology Market by Country
9.3.5.4 Asia Pacific Others Market by Country
9.3.6 Asia Pacific PET-CT Scanner Device Market by Country
9.3.6.1 China PET-CT Scanner Device Market
9.3.6.1.1 China PET-CT Scanner Device Market by Slice Count
9.3.6.1.2 China PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.1.3 China PET-CT Scanner Device Market by Service Provider
9.3.6.1.4 China PET-CT Scanner Device Market by Type
9.3.6.1.5 China PET-CT Scanner Device Market by Application
9.3.6.2 Japan PET-CT Scanner Device Market
9.3.6.2.1 Japan PET-CT Scanner Device Market by Slice Count
9.3.6.2.2 Japan PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.2.3 Japan PET-CT Scanner Device Market by Service Provider
9.3.6.2.4 Japan PET-CT Scanner Device Market by Type
9.3.6.2.5 Japan PET-CT Scanner Device Market by Application
9.3.6.3 India PET-CT Scanner Device Market
9.3.6.3.1 India PET-CT Scanner Device Market by Slice Count
9.3.6.3.2 India PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.3.3 India PET-CT Scanner Device Market by Service Provider
9.3.6.3.4 India PET-CT Scanner Device Market by Type
9.3.6.3.5 India PET-CT Scanner Device Market by Application
9.3.6.4 South Korea PET-CT Scanner Device Market
9.3.6.4.1 South Korea PET-CT Scanner Device Market by Slice Count
9.3.6.4.2 South Korea PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.4.3 South Korea PET-CT Scanner Device Market by Service Provider
9.3.6.4.4 South Korea PET-CT Scanner Device Market by Type
9.3.6.4.5 South Korea PET-CT Scanner Device Market by Application
9.3.6.5 Singapore PET-CT Scanner Device Market
9.3.6.5.1 Singapore PET-CT Scanner Device Market by Slice Count
9.3.6.5.2 Singapore PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.5.3 Singapore PET-CT Scanner Device Market by Service Provider
9.3.6.5.4 Singapore PET-CT Scanner Device Market by Type
9.3.6.5.5 Singapore PET-CT Scanner Device Market by Application
9.3.6.6 Malaysia PET-CT Scanner Device Market
9.3.6.6.1 Malaysia PET-CT Scanner Device Market by Slice Count
9.3.6.6.2 Malaysia PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.6.3 Malaysia PET-CT Scanner Device Market by Service Provider
9.3.6.6.4 Malaysia PET-CT Scanner Device Market by Type
9.3.6.6.5 Malaysia PET-CT Scanner Device Market by Application
9.3.6.7 Rest of Asia Pacific PET-CT Scanner Device Market
9.3.6.7.1 Rest of Asia Pacific PET-CT Scanner Device Market by Slice Count
9.3.6.7.2 Rest of Asia Pacific PET-CT Scanner Device Market by Isotope/Detector Type
9.3.6.7.3 Rest of Asia Pacific PET-CT Scanner Device Market by Service Provider
9.3.6.7.4 Rest of Asia Pacific PET-CT Scanner Device Market by Type
9.3.6.7.5 Rest of Asia Pacific PET-CT Scanner Device Market by Application
9.4 LAMEA PET-CT Scanner Device Market
9.4.1 LAMEA PET-CT Scanner Device Market by Slice Count
9.4.1.1 LAMEA Medium Slice Cardiology (64 Slices) Market by Country
9.4.1.2 LAMEA Low Slice Cardiology (< 64 Slices) Market by Country
9.4.1.3 LAMEA High Slice Cardiology (>64 Slices) Market by Country
9.4.2 LAMEA PET-CT Scanner Device Market by Isotope/Detector Type
9.4.2.1 LAMEA Flurodeoxyglucose (FDG) Market by Country
9.4.2.2 LAMEA 62Cu ATSM Market by Country
9.4.2.3 LAMEA 18 F Sodium Fluoride Market by Country
9.4.2.4 LAMEA FMISO Market by Country
9.4.2.5 LAMEA Gallium Market by Country
9.4.2.6 LAMEA Thallium Market by Country
9.4.2.7 LAMEA Others Market by Country
9.4.3 LAMEA PET-CT Scanner Device Market by Service Provider
9.4.3.1 LAMEA Hospitals Market by Country
9.4.3.2 LAMEA Diagnostic Centers Market by Country
9.4.3.3 LAMEA Research Institutes Market by Country
9.4.4 LAMEA PET-CT Scanner Device Market by Type
9.4.4.1 LAMEA Stationary Scanners Market by Country
9.4.4.2 LAMEA Portable Scanners/Mobile Scanners Market by Country
9.4.5 LAMEA PET-CT Scanner Device Market by Application
9.4.5.1 LAMEA Oncology Market by Country
9.4.5.2 LAMEA Cardiology Market by Country
9.4.5.3 LAMEA Neurology Market by Country
9.4.5.4 LAMEA Others Market by Country
9.4.6 LAMEA PET-CT Scanner Device Market by Country
9.4.6.1 Brazil PET-CT Scanner Device Market
9.4.6.1.1 Brazil PET-CT Scanner Device Market by Slice Count
9.4.6.1.2 Brazil PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.1.3 Brazil PET-CT Scanner Device Market by Service Provider
9.4.6.1.4 Brazil PET-CT Scanner Device Market by Type
9.4.6.1.5 Brazil PET-CT Scanner Device Market by Application
9.4.6.2 Argentina PET-CT Scanner Device Market
9.4.6.2.1 Argentina PET-CT Scanner Device Market by Slice Count
9.4.6.2.2 Argentina PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.2.3 Argentina PET-CT Scanner Device Market by Service Provider
9.4.6.2.4 Argentina PET-CT Scanner Device Market by Type
9.4.6.2.5 Argentina PET-CT Scanner Device Market by Application
9.4.6.3 UAE PET-CT Scanner Device Market
9.4.6.3.1 UAE PET-CT Scanner Device Market by Slice Count
9.4.6.3.2 UAE PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.3.3 UAE PET-CT Scanner Device Market by Service Provider
9.4.6.3.4 UAE PET-CT Scanner Device Market by Type
9.4.6.3.5 UAE PET-CT Scanner Device Market by Application
9.4.6.4 Saudi Arabia PET-CT Scanner Device Market
9.4.6.4.1 Saudi Arabia PET-CT Scanner Device Market by Slice Count
9.4.6.4.2 Saudi Arabia PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.4.3 Saudi Arabia PET-CT Scanner Device Market by Service Provider
9.4.6.4.4 Saudi Arabia PET-CT Scanner Device Market by Type
9.4.6.4.5 Saudi Arabia PET-CT Scanner Device Market by Application
9.4.6.5 South Africa PET-CT Scanner Device Market
9.4.6.5.1 South Africa PET-CT Scanner Device Market by Slice Count
9.4.6.5.2 South Africa PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.5.3 South Africa PET-CT Scanner Device Market by Service Provider
9.4.6.5.4 South Africa PET-CT Scanner Device Market by Type
9.4.6.5.5 South Africa PET-CT Scanner Device Market by Application
9.4.6.6 Nigeria PET-CT Scanner Device Market
9.4.6.6.1 Nigeria PET-CT Scanner Device Market by Slice Count
9.4.6.6.2 Nigeria PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.6.3 Nigeria PET-CT Scanner Device Market by Service Provider
9.4.6.6.4 Nigeria PET-CT Scanner Device Market by Type
9.4.6.6.5 Nigeria PET-CT Scanner Device Market by Application
9.4.6.7 Rest of LAMEA PET-CT Scanner Device Market
9.4.6.7.1 Rest of LAMEA PET-CT Scanner Device Market by Slice Count
9.4.6.7.2 Rest of LAMEA PET-CT Scanner Device Market by Isotope/Detector Type
9.4.6.7.3 Rest of LAMEA PET-CT Scanner Device Market by Service Provider
9.4.6.7.4 Rest of LAMEA PET-CT Scanner Device Market by Type
9.4.6.7.5 Rest of LAMEA PET-CT Scanner Device Market by Application
Chapter 10. Company Profiles
10.1 Bruker Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers
10.2 Toshiba Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research and Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Approvals and Trials:
10.4 General Electric (GE) Co. (GE Healthcare)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.4.5.3 Acquisition and Mergers
10.4.6 SWOT Analysis
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Product Launches and Product Expansions:
10.6 Shimadzu Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Positron Corporation
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 PerkinElmer, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Mediso Ltd.
10.9.1 Company Overview
10.10. Hitachi, Ltd. (Hitachi Healthcare)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expenses

Companies Mentioned

  • Bruker Corporation
  • Toshiba Corporation
  • Siemens Healthineers AG (Siemens AG)
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • Positron Corporation
  • PerkinElmer, Inc.
  • Mediso Ltd.
  • Hitachi, Ltd. (Hitachi Healthcare)

Methodology

Loading
LOADING...